In addition to being an adjunct professor at KGI, Mr. Anicetti is the senior vice president of global quality at Coherus Biosciences. A leading biologics platform company, Coherus focused on delivering high-quality biosimilar therapeutics that will expand patient access to life-changing medications. Prior to joining Coherus, he was the executive director of quality for Boehringer-Ingelheim’s California facility, responsible for quality and on-site regulatory chemistry, manufacturing, and control. Previously, he spent 30 years with Genentech and held senior leadership roles in quality, regulatory affairs and project portfolio management, including vice president of biologics quality for Genentech and Roche Biologics manufacturing sites around the world.
At KGI, he teaches classes in biopharmaceutical quality and CMC regulatory affairs. Mr. Anicetti has been very active in the Parenteral Drug Association (PDA), serving as past chair and member of the executive committee. He was also the leader of the PDA Biotech Interest group, editor of the PDA newsletter and served as co-chairman of the 2012 annual meeting. He holds B.A. and M.S. degrees in biological sciences from San Francisco State University and serves on the San Francisco State University Foundation Board.